Evogene ltd. (EVGN)
Balance Sheet / Quarterly
Dec'17Dec'16
CURRENT ASSETS:
Cash and cash equivalents

3,435

3,236

Restricted cash

47

47

Marketable securities

59,940

71,738

Short-term bank deposits

8,380

13,137

Trade receivables

132

169

Other receivables

857

1,163

Total current assets

72,791

89,490

LONG-TERM ASSETS:
Long-term deposits

19

13

Property, plant and equipment, net

4,792

6,483

Total long term assets

4,811

6,496

Total assets

77,602

95,986

CURRENT LIABILITIES:
Trade payables

1,110

1,330

Other payables

2,934

2,803

Liabilities in respect of government grants

104

125

Deferred revenues and other advances

516

967

Total current liabilities

4,664

5,225

LONG-TERM LIABILITIES:
Liabilities in respect of government grants

3,438

3,303

Deferred revenues and other advances

89

138

Severance pay liability, net

33

31

Total non-current liabilities

3,560

3,472

SHAREHOLDERS' EQUITY:
Ordinary shares of NIS 0.02 par value: Authorized - 150,000,000 ordinary shares; Issued and outstanding - 25,750,547 and 25,480,809 shares at December 31, 2017 and 2016, respectively

142

141

Share premium and other capital reserve

186,268

183,342

Accumulated deficit

-117,032

-96,194

Shareholder's Equity

69,378

87,289

Shareholder's Equity and Liabilities

77,602

95,986